Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -45.74x is 186% below its 5-year average of 53.40x, near the low end of its 5-year range (-434.23x–2219.99x).
61.29% above its 12-month average of -118.17x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -120.01x.
INTEREST COVERAGE RATIO
-45.74x
INTEREST COVERAGE RATIO AVG TTM
-118.17x
INTEREST COVERAGE RATIO AVG 3Y
-77.30x
INTEREST COVERAGE RATIO AVG 5Y
53.40x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+61.29%
CURRENT VS 3Y AVG
+40.83%
CURRENT VS 5Y AVG
-185.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
-764.34%
vs the sector median at left
BioNTech SE
Market Cap
$24.49B
Interest Coverage Ratio
-45.74x
TTM Avg
-118.17x
3Y Avg
-77.30x
5Y Avg
53.40x
Market Cap
$24.63B
Interest Coverage Ratio
553.04x
TTM Avg
298.73x
3Y Avg
269.07x
5Y Avg
276.66x
Market Cap
$25.92B
Interest Coverage Ratio
1029.00x
TTM Avg
617.01x
3Y Avg
353.82x
5Y Avg
258.97x
Market Cap
$26.29B
Interest Coverage Ratio
6.77x
TTM Avg
5.99x
3Y Avg
5.91x
5Y Avg
8.30x
Market Cap
$26.79B
Interest Coverage Ratio
16.32x
TTM Avg
15.71x
3Y Avg
16.43x
5Y Avg
18.17x
Market Cap
$27.17B
Interest Coverage Ratio
5.79x
TTM Avg
5.88x
3Y Avg
7.29x
5Y Avg
9.45x
Market Cap
$27.19B
Interest Coverage Ratio
2.72x
TTM Avg
2.21x
3Y Avg
1.60x
5Y Avg
1.60x
Market Cap
$21.40B
Interest Coverage Ratio
77.81x
TTM Avg
54.95x
3Y Avg
40.03x
5Y Avg
35.88x
Market Cap
$20.79B
Interest Coverage Ratio
18.15x
TTM Avg
14.10x
3Y Avg
10.28x
5Y Avg
10.20x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $24.49B | -45.74x | -118.17x | -77.30x | 53.40x |
| Incyte Corporation (INCY)vs › | $24.63B | 553.04x | 298.73x | 269.07x | 276.66x |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.92B | 1029.00x | 617.01x | 353.82x | 258.97x |
| Labcorp Holdings Inc. (LH)vs › | $26.29B | 6.77x | 5.99x | 5.91x | 8.30x |
| Mettler-Toledo International Inc. (MTD)vs › | $26.79B | 16.32x | 15.71x | 16.43x | 18.17x |
| Quest Diagnostics Incorporated (DGX)vs › | $27.17B | 5.79x | 5.88x | 7.29x | 9.45x |
| Medline Inc. (MDLN)vs › | $27.19B | 2.72x | 2.21x | 1.60x | 1.60x |
| United Therapeutics Corporation (UTHR)vs › | $21.40B | 77.81x | 54.95x | 40.03x | 35.88x |
| STERIS plc (STE)vs › | $20.79B | 18.15x | 14.10x | 10.28x | 10.20x |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.02B | 6.14x | 5.67x | 11.29x | 26.04x |
Interest Coverage
-45.7x
Debt/Equity
0.02
Current Ratio
7.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -120.01x |
| 2026-03-31 | -165.28x |
| 2025-12-31 | -35.82x |
| 2025-09-30 | -117.52x |
| 2025-06-30 | -152.21x |
| 2025-03-31 | -85.83x |
| 2024-09-30 | 2.01x |
| 2024-06-30 | -131.94x |
| 2024-03-31 | -106.85x |
| 2023-12-31 | 27.76x |
| 2023-09-30 | 35.43x |
| 2023-06-30 | -434.23x |
| 2023-03-31 | 552.72x |
| 2022-12-31 | 1568.05x |
| 2022-09-30 | 538.66x |
| 2022-06-30 | 374.54x |
| 2022-03-31 | 700.03x |
| 2021-12-31 | 2219.99x |
| 2021-09-30 | 56.26x |
| 2021-06-30 | 23.49x |
| 2021-03-31 | 36.33x |
| 2020-12-31 | 6.42x |
| 2020-09-30 | -8.66x |
| 2020-06-30 | -8.47x |
| 2020-03-31 | -113.07x |
| 2019-12-31 | -262.09x |
| 2019-09-30 | -71.60x |
| 2019-06-30 | -18.21x |
| 2019-03-31 | -87.85x |
| 2018-12-31 | -5.82x |
| 2018-09-30 | -13.37x |
